These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 37240178)

  • 1. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
    Zhu YZ; Liu Y; Liao XW; Luo SS
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
    Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.
    Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
    Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
    Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC).
    Łukaszewicz-Zając M; Szmitkowski M; Litman-Zawadzka A; Mroczko B
    Cancer Invest; 2016 Aug; 34(7):305-12. PubMed ID: 27414231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
    Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.
    Pawluczuk E; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.
    de la Peña S; Sampieri CL; Ochoa-Lara M; León-Córdoba K; Remes-Troche JM
    Dis Markers; 2014; 2014():285906. PubMed ID: 24669030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.
    Wang X; Chen X; Fang J; Yang C
    Int J Clin Exp Pathol; 2013; 6(4):586-97. PubMed ID: 23573305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
    Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
    Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel potential biomarkers for pancreatic cancer - A systematic review.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Mroczko B
    Adv Med Sci; 2019 Sep; 64(2):252-257. PubMed ID: 30844662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
    Cheng Y; Yang B; Xi Y; Chen X
    Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
    Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
    Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
    Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
    Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
    He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
    World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
    Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of interleukin-6 and C-reactive protein in gastric cancer].
    Łukaszewicz-Zajac M; Mroczko B; Szmitkowski M
    Pol Merkur Lekarski; 2010 Dec; 29(174):382-6. PubMed ID: 21298990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.